Marc Engelen

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint X-linked adrenoleukodystrophy: pathogenesis and treatment
    Marc Engelen
    Department of Pediatric Neurology Emma Children s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, 1100 DD, The Netherlands
    Curr Neurol Neurosci Rep 14:486. 2014
  2. pmc X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
    Marc Engelen
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Orphanet J Rare Dis 7:51. 2012
  3. pmc A 64-year old man presenting with carotid artery occlusion and corticobasal syndrome: a case report
    Marc Engelen
    Department of Neurology, H2, 216, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    J Med Case Reports 5:357. 2011
  4. pmc Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
    Marc Engelen
    Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Inherit Metab Dis 35:1137-45. 2012
  5. ncbi request reprint X-linked adrenoleukodystrophy in women: a cross-sectional cohort study
    Marc Engelen
    1 Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Brain 137:693-706. 2014
  6. pmc Bezafibrate for X-linked adrenoleukodystrophy
    Marc Engelen
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS ONE 7:e41013. 2012
  7. doi request reprint Peroxisomal leukoencephalopathy
    Bwee Tien Poll-The
    Department of Pediatric Neurology Pediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Semin Neurol 32:42-50. 2012

Collaborators

Detail Information

Publications8

  1. ncbi request reprint X-linked adrenoleukodystrophy: pathogenesis and treatment
    Marc Engelen
    Department of Pediatric Neurology Emma Children s Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, 1100 DD, The Netherlands
    Curr Neurol Neurosci Rep 14:486. 2014
    ..This review proposes to simplify the classification of the clinical spectrum of X-ALD and reviews the largely unresolved pathophysiological mechanisms and the current treatment options. ..
  2. pmc X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
    Marc Engelen
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Orphanet J Rare Dis 7:51. 2012
    ..This review focuses on the diagnosis and management of patients with X-ALD and provides a guideline for clinicians that encounter patients with this highly complex disorder...
  3. pmc A 64-year old man presenting with carotid artery occlusion and corticobasal syndrome: a case report
    Marc Engelen
    Department of Neurology, H2, 216, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    J Med Case Reports 5:357. 2011
    ..abstract:..
  4. pmc Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
    Marc Engelen
    Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Inherit Metab Dis 35:1137-45. 2012
    ..Taken together, our data indicate bezafibrate as a potential pharmacotherapeutic treatment for X-ALD. A clinical trial is currently ongoing to evaluate the effect in patients with X-ALD...
  5. ncbi request reprint X-linked adrenoleukodystrophy in women: a cross-sectional cohort study
    Marc Engelen
    1 Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Brain 137:693-706. 2014
    ..ABCD1 mutation analysis deserves a place in diagnostic protocols for chronic non-compressive myelopathy. ..
  6. pmc Bezafibrate for X-linked adrenoleukodystrophy
    Marc Engelen
    Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS ONE 7:e41013. 2012
    ..Our future work is aimed at the identification of highly-specific inhibitors of ELOVL1 that act at much lower concentrations than BF and are well tolerated. BF appears to have no therapeutic utility in X-ALD...
  7. doi request reprint Peroxisomal leukoencephalopathy
    Bwee Tien Poll-The
    Department of Pediatric Neurology Pediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Semin Neurol 32:42-50. 2012
    ....